Burning Rock Biotech (BNR) Leases: 2020-2025
Historic Leases for Burning Rock Biotech (BNR) over the last 6 years, with Sep 2025 value amounting to $4.5 million.
- Burning Rock Biotech's Leases fell 67.96% to $4.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.5 million, marking a year-over-year decrease of 67.96%. This contributed to the annual value of $7.3 million for FY2024, which is 321.21% up from last year.
- As of Q3 2025, Burning Rock Biotech's Leases stood at $4.5 million, which was down 14.90% from $5.3 million recorded in Q2 2025.
- Burning Rock Biotech's Leases' 5-year high stood at $15.1 million during Q1 2021, with a 5-year trough of $1.7 million in Q4 2023.
- Its 3-year average for Leases is $6.3 million, with a median of $5.3 million in 2025.
- In the last 5 years, Burning Rock Biotech's Leases skyrocketed by 460.74% in 2021 and then crashed by 75.25% in 2023.
- MRQ analysis of 5 years shows Burning Rock Biotech's Leases stood at $12.7 million in 2021, then crashed by 45.02% to $7.0 million in 2022, then crashed by 75.25% to $1.7 million in 2023, then soared by 321.21% to $7.3 million in 2024, then crashed by 37.78% to $4.5 million in 2025.
- Its last three reported values are $4.5 million in Q3 2025, $5.3 million for Q2 2025, and $6.0 million during Q1 2025.